A clinical evaluation of sulbactam/ampicillin in the treatment of pediatric infections.

L. M. Huang, C. Y. Lee, M. J. Lee, C. Y. Hsu, Ching-Chuan Liu, J. Y. Hong, J. M. Chen

研究成果: Article同行評審

2 引文 斯高帕斯(Scopus)

摘要

We have treated 42 episodes of pediatric infections with sulbactam/ampicillin since 1987. Included were 9 cellulitis, 9 urinary tract infections, 5 cervical lymphadenitis, 4 meningitis, 2 thoracic empyema, 2 osteomyelitis, 2 sepsis, 1 furuncle, 1 perianal abscess, 1 dental abscess, 1 peritonsillitis, 1 salmonellosis, 1 shigellosis, 1 peritonitis, 1 suppurative thyroiditis, 1 infective endocarditis. Responsible pathogens were Escherichia coli in 8, Staphylococcus aureus in 6, Hemophilus influenzae in 2, Streptococcus pneumoniae in 3, Streptococcus viridans in 2, Staphylococcus epidermidis in 1, Bacteroides fragilis in 1, Salmonella D1 in 1, Shigella sonnei in 1, Klebsiella pneumoniae in 1, Enterobacter agglomerans in 1, Acinetobacter calcoaceticus in 1, Enterobacter cloacae in 1, group A beta-hemolytic streptococcus in 1, and polymicrobial infection in 4 cases. Thirty-nine out of 41 (95%) clinically evaluable patients cured and all (34/34) bacteriologically evaluable patients eradicated their pathogens after treatment with sulbactam/ampicillin. Side reactions were seen in five patients; one maculopapular skin rash, one hemolytic anemia, two diarrhea, and one liver function impairment plus leukopenia. All these reactions were transient and did not require interruption of therapy. These results indicate that sulbactam/ampicillin is safe and effective in the treatment of common pediatric infections beyond the neonatal period.

原文English
頁(從 - 到)87-93
頁數7
期刊Acta Paediatrica Sinica
30
發行號2
出版狀態Published - 1989 三月 1

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

指紋 深入研究「A clinical evaluation of sulbactam/ampicillin in the treatment of pediatric infections.」主題。共同形成了獨特的指紋。

引用此